nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—SHBG—Nongenotropic Androgen signaling—PTK2—malignant glioma	0.0717	0.0774	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—RAF1—malignant glioma	0.0408	0.044	CbGpPWpGaD
Equilin—Ethinyl Estradiol—CYP2B6—malignant glioma	0.0386	0.534	CrCbGaD
Equilin—Estrone—CYP2B6—malignant glioma	0.0336	0.465	CrCbGaD
Equilin—HSD17B1—Metabolism—RTEL1—malignant glioma	0.0269	0.0291	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—PIK3CA—malignant glioma	0.0243	0.0262	CbGpPWpGaD
Equilin—SHBG—Nongenotropic Androgen signaling—AKT1—malignant glioma	0.0198	0.0214	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.0192	0.0208	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LATS2—malignant glioma	0.0191	0.0207	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.0186	0.0201	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—COX8A—malignant glioma	0.0155	0.0167	CbGpPWpGaD
Equilin—HSD17B1—Disease—BCAN—malignant glioma	0.0148	0.0159	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LATS1—malignant glioma	0.0145	0.0157	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.0138	0.0149	CbGpPWpGaD
Equilin—HSD17B1—Disease—DTX1—malignant glioma	0.0133	0.0144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ASMT—malignant glioma	0.0131	0.0142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.0129	0.0139	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BCAN—malignant glioma	0.0124	0.0133	CbGpPWpGaD
Equilin—HSD17B1—Disease—HEY2—malignant glioma	0.0105	0.0113	CbGpPWpGaD
Equilin—HSD17B1—Disease—IDH1—malignant glioma	0.0102	0.011	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—IDH2—malignant glioma	0.00996	0.0108	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MDK—malignant glioma	0.0098	0.0106	CbGpPWpGaD
Equilin—HSD17B1—Disease—HEY1—malignant glioma	0.0097	0.0105	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIST1H3B—malignant glioma	0.00942	0.0102	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.0094	0.0101	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2B6—malignant glioma	0.00937	0.0101	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DTX1—malignant glioma	0.00935	0.0101	CbGpPWpGaD
Equilin—HSD17B1—Disease—JAG2—malignant glioma	0.0086	0.00928	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—IDH1—malignant glioma	0.00857	0.00925	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SPHK1—malignant glioma	0.00829	0.00895	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2C18—malignant glioma	0.00812	0.00877	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00766	0.00827	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SUFU—malignant glioma	0.00743	0.00802	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HEY2—malignant glioma	0.00734	0.00792	CbGpPWpGaD
Equilin—HSD17B1—Disease—H3F3A—malignant glioma	0.00728	0.00786	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GFAP—malignant glioma	0.00716	0.00773	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00698	0.00753	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SPHK1—malignant glioma	0.00693	0.00748	CbGpPWpGaD
Equilin—HSD17B1—Disease—JAG1—malignant glioma	0.00686	0.00741	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR4—malignant glioma	0.00679	0.00733	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HEY1—malignant glioma	0.00679	0.00733	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00673	0.00727	CbGpPWpGaD
Equilin—HSD17B1—Disease—FBXW7—malignant glioma	0.00672	0.00726	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIST1H3B—malignant glioma	0.0066	0.00712	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTT1—malignant glioma	0.00657	0.00709	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS1—malignant glioma	0.00616	0.00664	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.00613	0.00662	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAG2—malignant glioma	0.00602	0.0065	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BCHE—malignant glioma	0.00572	0.00618	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC5A5—malignant glioma	0.00565	0.0061	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00535	0.00577	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.0053	0.00572	CbGpPWpGaD
Equilin—HSD17B1—Disease—CDKN2B—malignant glioma	0.00527	0.00569	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—H3F3A—malignant glioma	0.0051	0.0055	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCR3—malignant glioma	0.00505	0.00545	CbGpPWpGaD
Equilin—HSD17B1—Disease—HES1—malignant glioma	0.00503	0.00542	CbGpPWpGaD
Equilin—HSD17B1—Disease—NCOR1—malignant glioma	0.005	0.00539	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NTRK2—malignant glioma	0.00491	0.0053	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—YWHAE—malignant glioma	0.00491	0.0053	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FLT1—malignant glioma	0.00489	0.00528	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DUSP6—malignant glioma	0.00487	0.00525	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAG1—malignant glioma	0.00481	0.00519	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH3—malignant glioma	0.00479	0.00516	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDGFRA—malignant glioma	0.00479	0.00516	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FBXW7—malignant glioma	0.00471	0.00508	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.00462	0.00499	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BDKRB2—malignant glioma	0.00462	0.00498	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTP1—malignant glioma	0.00455	0.00491	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CAT—malignant glioma	0.00443	0.00478	CbGpPWpGaD
Equilin—HSD17B1—Disease—HLA-A—malignant glioma	0.0044	0.00475	CbGpPWpGaD
Equilin—HSD17B1—Disease—TERT—malignant glioma	0.0044	0.00475	CbGpPWpGaD
Equilin—HSD17B1—Disease—PDGFB—malignant glioma	0.0043	0.00464	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH2—malignant glioma	0.00429	0.00463	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGFR1—malignant glioma	0.00428	0.00461	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIF1A—malignant glioma	0.00421	0.00455	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KNG1—malignant glioma	0.0042	0.00453	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NCOR1—malignant glioma	0.00418	0.00452	CbGpPWpGaD
Equilin—HSD17B1—Disease—CAV1—malignant glioma	0.00407	0.0044	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NTRK1—malignant glioma	0.004	0.00432	CbGpPWpGaD
Equilin—HSD17B1—Disease—BAD—malignant glioma	0.00383	0.00413	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOTCH1—malignant glioma	0.00379	0.00409	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP3—malignant glioma	0.00372	0.00402	CbGpPWpGaD
Equilin—HSD17B1—Disease—CD80—malignant glioma	0.00372	0.00401	CbGpPWpGaD
Equilin—HSD17B1—Disease—APC—malignant glioma	0.00371	0.004	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CDKN2B—malignant glioma	0.00369	0.00398	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGF—malignant glioma	0.00367	0.00396	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTPN11—malignant glioma	0.00365	0.00393	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTK2—malignant glioma	0.00358	0.00387	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HES1—malignant glioma	0.00352	0.0038	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NCOR1—malignant glioma	0.0035	0.00378	CbGpPWpGaD
Equilin—HSD17B1—Disease—BRAF—malignant glioma	0.00349	0.00376	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CAV1—malignant glioma	0.00341	0.00368	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT2—malignant glioma	0.00339	0.00366	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFRA—malignant glioma	0.00335	0.00362	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CD—malignant glioma	0.00326	0.00352	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.00326	0.00352	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SPP1—malignant glioma	0.00325	0.00351	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF2—malignant glioma	0.00312	0.00337	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CG—malignant glioma	0.00311	0.00335	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TERT—malignant glioma	0.00308	0.00333	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDGFB—malignant glioma	0.00301	0.00325	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARG—malignant glioma	0.003	0.00324	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGFR1—malignant glioma	0.00299	0.00323	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIF1A—malignant glioma	0.00295	0.00318	CbGpPWpGaD
Equilin—HSD17B1—Disease—MDM2—malignant glioma	0.00292	0.00315	CbGpPWpGaD
Equilin—HSD17B1—Disease—RAF1—malignant glioma	0.00291	0.00314	CbGpPWpGaD
Equilin—HSD17B1—Disease—ERBB2—malignant glioma	0.00288	0.00311	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CAV1—malignant glioma	0.00285	0.00308	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CB—malignant glioma	0.00284	0.00307	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KDR—malignant glioma	0.00282	0.00304	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—malignant glioma	0.00282	0.00304	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CD—malignant glioma	0.00273	0.00295	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FN1—malignant glioma	0.00271	0.00293	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—F2—malignant glioma	0.00271	0.00293	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BAD—malignant glioma	0.00268	0.0029	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOTCH1—malignant glioma	0.00266	0.00287	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CD80—malignant glioma	0.0026	0.00281	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APC—malignant glioma	0.0026	0.0028	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CG—malignant glioma	0.0026	0.0028	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGF—malignant glioma	0.00257	0.00277	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTPN11—malignant glioma	0.00255	0.00275	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTEN—malignant glioma	0.00246	0.00265	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BRAF—malignant glioma	0.00244	0.00264	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CB—malignant glioma	0.00238	0.00257	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT2—malignant glioma	0.00238	0.00257	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—malignant glioma	0.00236	0.00255	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CD—malignant glioma	0.00228	0.00247	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT3—malignant glioma	0.0022	0.00237	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF2—malignant glioma	0.00219	0.00236	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTEN—malignant glioma	0.00206	0.00222	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MDM2—malignant glioma	0.00205	0.00221	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—malignant glioma	0.00204	0.0022	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAF1—malignant glioma	0.00204	0.0022	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ERBB2—malignant glioma	0.00202	0.00218	CbGpPWpGaD
Equilin—HSD17B1—Disease—EGFR—malignant glioma	0.002	0.00216	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CB—malignant glioma	0.00199	0.00215	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—malignant glioma	0.00191	0.00206	CbGpPWpGaD
Equilin—HSD17B1—Disease—KRAS—malignant glioma	0.00189	0.00204	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—malignant glioma	0.00183	0.00198	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL2—malignant glioma	0.00183	0.00197	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—malignant glioma	0.00173	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—malignant glioma	0.00173	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTEN—malignant glioma	0.00172	0.00186	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—malignant glioma	0.00155	0.00168	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT3—malignant glioma	0.00154	0.00166	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—malignant glioma	0.00145	0.00157	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—malignant glioma	0.00143	0.00154	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—malignant glioma	0.00142	0.00153	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EGFR—malignant glioma	0.0014	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KRAS—malignant glioma	0.00132	0.00143	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—malignant glioma	0.00121	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—malignant glioma	0.00119	0.00128	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TP53—malignant glioma	0.00117	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—malignant glioma	0.000991	0.00107	CbGpPWpGaD
Equilin—HSD17B1—central nervous system—malignant glioma	0.000499	0.385	CbGeAlD
Equilin—HSD17B1—brain—malignant glioma	0.000396	0.306	CbGeAlD
Equilin—SHBG—brainstem—malignant glioma	0.000167	0.129	CbGeAlD
Equilin—SHBG—central nervous system—malignant glioma	8.41e-05	0.065	CbGeAlD
Equilin—SHBG—cerebellum—malignant glioma	8.22e-05	0.0635	CbGeAlD
Equilin—SHBG—brain—malignant glioma	6.68e-05	0.0516	CbGeAlD
